City Drug House – Type 2 Diabetes Pharma Exporter to USA
City Drug House is a trusted Indian pharmaceutical exporter specializing in Type 2 Diabetes medicines for the USA and Washington markets. We provide high-quality diabetic medications manufactured under strict quality standards with reliable international shipping.
Obesema 0.5 mg injection (containing semaglutide) is a once-weekly prescription medication used primarily for long-term weight management in adults and adolescents (12+) with obesity or weight-related conditions. As a GLP-1 receptor agonist, it assists in appetite regulation, lowers blood sugar in type 2 diabetes, and reduces the risk of major cardiovascular events (heart attack, stroke).
Key Therapeutic Applications :
1.Weight Management: Promotes sustained weight loss in individuals with obesity or overweight with comorbidities like hypertension, type 2 diabetes, or high cholesterol.
2.Type 2 Diabetes Mellitus: Improves glycemic control by increasing insulin secretion, reducing glucose production in the liver, and lowering fasting/post-meal blood sugar levels.
3.Cardiovascular Risk Reduction: Reduces the risk of major adverse cardiovascular events (MACE) in adults with both established heart disease and obesity/overweight.
City Drug House Exporters provides:
Bulk supply for hospitals & distributors
Export to USA. Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics
Contact for More Information :
📞 Contact City drug House Exporters from India
🌐 Websites:
https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 9975390171
City Drug House is a trusted Indian pharmaceutical exporter specializing in Type 2 Diabetes medicines for the USA and Washington markets. We provide high-quality diabetic medications manufactured under strict quality standards with reliable international shipping.
Obesema 0.5 mg injection (containing semaglutide) is a once-weekly prescription medication used primarily for long-term weight management in adults and adolescents (12+) with obesity or weight-related conditions. As a GLP-1 receptor agonist, it assists in appetite regulation, lowers blood sugar in type 2 diabetes, and reduces the risk of major cardiovascular events (heart attack, stroke).
Key Therapeutic Applications :
1.Weight Management: Promotes sustained weight loss in individuals with obesity or overweight with comorbidities like hypertension, type 2 diabetes, or high cholesterol.
2.Type 2 Diabetes Mellitus: Improves glycemic control by increasing insulin secretion, reducing glucose production in the liver, and lowering fasting/post-meal blood sugar levels.
3.Cardiovascular Risk Reduction: Reduces the risk of major adverse cardiovascular events (MACE) in adults with both established heart disease and obesity/overweight.
City Drug House Exporters provides:
Bulk supply for hospitals & distributors
Export to USA. Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics
Contact for More Information :
📞 Contact City drug House Exporters from India
🌐 Websites:
https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 9975390171
Keywords
